Advertisement

Topics

Novus Therapeutics, Inc. Company Profile

05:11 EST 12th December 2018 | BioPortfolio

Novus Therapeutics is a specialty pharmaceutical company focused on developing products for disorders of the ear, nose, and throat (ENT). Novus has two technologies, each that has the potential to be developed for multiple ENT indications. The company’s lead product (OP-02) is a surfactant-based, combination drug product being developed as a potential first-in-class treatment option for patients at risk for or with otitis media (“OM”) (middle ear inflammation with or without infection). Globally, OM affects more than 700 million adults and children every year. OM is a common disorder seen in pediatric practice, and in the United States is the most frequent reason children are prescribed antibiotics and undergo surgery. Novus also has a foam-based drug delivery technology (OP-01), which may be developed in the future to deliver drugs into the ear, nasal, and sinus cavities. For more information please visit novustherapeutics.com.


News Articles [715 Associated News Articles listed on BioPortfolio]

Novus Therapeutics doses first subject in Phase I trial of OP0201

Novus Therapeutics has dosed the first adult subjects in a Phase I clinical trial designed to evaluate the safety and...Read More... The post Novus Therapeutics doses first subject in Phase I trial of...

Novus Therapeutics to Present at the 2018 Piper Jaffray Healthcare Conference

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today an...

Novus Therapeutics to Present at the Ladenburg Thalmann 2018 Healthcare Conference

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”), to...

Boeing, Novus Aviation Announce Commitment For Up To Four 777-300ERs

CHICAGO (dpa-AFX) - Boeing (BA) and Dubai-based aircraft lessor, Novus Aviation Capital, announced its first direct agreement with Boeing for up to four 777-300ERs (Extended Range) at the 2018 Far...

5 Top Weekly NASDAQ Biotech Stocks: resTORbio Leads the Pack

resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index. The post 5 Top Weekly NASDAQ Biotech Stocks: res...

Novus Therapeutics to Postpone Offering of Common Stock

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”), to...

Novus Therapeutics Receives FDA Guidance at Type C Meeting for OP-02 in the Treatment and Prevention of Otitis Media

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), announce...

Novus Therapeutics Inc NVUS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23042018] Prices from USD $250

SummaryNovus Therapeutics Inc Tokai Pharma, formerly Tokai Pharmaceuticals Inc is a pharmaceutical company that offers acquisition, development and commercialization of ear, nose and throat ENT produc...

PubMed Articles [459 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Eyes on New Product Development.

Clinical Trials [164 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1289 Associated Companies listed on BioPortfolio]

Novus Therapeutics, Inc.

Novus Therapeutics is a specialty pharmaceutical company focused on developing products for disorders of the ear, nose, and throat (ENT). Novus has two technologies, each that has...

NOVUS INTERNATIONAL

Novus International, Inc., a global leader in the animal agriculture industry, is a privately held corporation headquartered in St. Louis, Missouri. Formed as a joint venture in 1991, the Novus corpor...

Novus International, Inc.

Novus International, Inc. is headquartered in metropolitan St. Louis, Missouri, U.S.A. and serves customers in more than 90 countries around the world. An industry leader in anima...

Novus Biologicals, Inc

The mission of Novus Biologicals, Inc. is to accelerate scientific discovery by marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological researc...

Novus Biologicals Incorporated

Our mission at Novus Biologicals, Inc. is to supply monoclonal and polyclonal antibodies, recombinant protein and cDNAs for the scientific research community that are of high quality and applicability...

More Information about "Novus Therapeutics, Inc." on BioPortfolio

We have published hundreds of Novus Therapeutics, Inc. news stories on BioPortfolio along with dozens of Novus Therapeutics, Inc. Clinical Trials and PubMed Articles about Novus Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novus Therapeutics, Inc. Companies in our database. You can also find out about relevant Novus Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record